Related Experiment Videos
Molecular imaging of cell-based therapies
Dawid Schellingerhout1, Lee Josephson
1Department of Radiology, Center for Molecular Imaging Research, Massachusetts General Hospital, Room 5403, Building 149, 13th Street, Charlestown, MA 02129, USA. Dawid@helix.mgh.harvard.edu
Neuroimaging Clinics of North America
|June 9, 2004
Summary
Molecular imaging is crucial for tracking novel cell-based therapies like stem cell therapies and immunocyte infusions. This review covers animal models, clinical uses, and future directions for these advanced treatments.
Area of Science:
- Biomedical imaging
- Cellular therapy research
- Regenerative medicine
Background:
- Cell-based therapies, including stem cell therapies and adoptive immunocyte transfer, represent a promising frontier in medicine.
- Effective monitoring of these therapies in vivo is essential for assessing efficacy and safety.
- Molecular imaging techniques offer non-invasive methods to track cell behavior and distribution.
Purpose of the Study:
- To review the application of molecular imaging for novel cell-based therapies.
- To discuss the current state and future potential of imaging stem cell therapies and immunocyte transfers.
- To highlight the role of imaging in preclinical and clinical development.
Main Methods:
- Review of existing literature on molecular imaging in cell therapy.
- Discussion of various imaging modalities (e.g., PET, SPECT, MRI, optical imaging).
- Analysis of animal models used for evaluating cell-based therapies.
Main Results:
- Molecular imaging enables visualization of cell migration, engraftment, and biodistribution.
- Different imaging modalities have specific advantages for tracking various cell types.
- Successful preclinical imaging studies inform potential clinical applications.
Conclusions:
- Molecular imaging is indispensable for advancing cell-based therapeutic strategies.
- Further development of imaging probes and techniques will enhance clinical translation.
- Imaging plays a critical role in optimizing cell therapy protocols and patient outcomes.